Aseptic Production Solution for Lyophilized Injectables | Filter Integrity Tester & Full QC Equipment

Lyophilized injectables are typical sterile preparations. Their production process covers liquid preparation, sterile filtration, aseptic filling, partial stoppering, freeze-drying, stoppering & crimping, finished product storage and other stages. As products transform from liquid into solid lyophilized state, with critical processes including sterile filtration and aseptic operations, their quality control features obvious full-process characteristics.

For lyophilized injectables, the final product quality is not determined by a single test item. Instead, it relies on multiple QC links including pharmaceutical water quality, integrity of critical filtration systems, aseptic operation barriers, freeze-drying process control, and integrity of the final container closure system. Therefore, to build a detection system matching manufacturing processes, it is necessary to start from the actual production workflow of lyophilized injectables, deploy corresponding analytical and integrity testing technologies at process nodes with clear quality risks, and realize effective correlation between test data and production processes.

With years of R&D experience in pharmaceutical testing equipment, MedIntegrity centers on the typical manufacturing process of lyophilized injectables. It integrates total organic carbon analysis, filter integrity testing, glove integrity testing for operations, single-use process bag integrity testing, container closure integrity testing and other technologies into production workflows, helping pharmaceutical companies build a full-process integrity QC solution covering critical process nodes.

I. Quality Control of Pharmaceutical Water

The production of lyophilized injectables usually starts with preparation of pharmaceutical water and raw & auxiliary materials. Purified water, Water for Injection (WFI) are not only used for liquid preparation, but also widely applied in cleaning of production equipment and relevant systems. Hence the water system serves as an important foundation of the quality system for sterile drug manufacturing.

In pharmaceutical water quality control, Total Organic Carbon (TOC) is a key indicator to assess organic contamination levels in water. Continuous TOC monitoring on water systems, combined with the enterprise’s established water system monitoring plan, sampling strategy and quality standards, can be used to evaluate the status of water systems.

MedIntegrity TA-series total organic carbon analyzers adapt to different water system architectures and testing modes, supporting off-line laboratory testing or on-line continuous monitoring. For QC laboratories requiring multi-batch and multi-sample testing, auto-sampler systems can be integrated to improve automation and testing efficiency.

Within the production workflow of lyophilized injectables, TOC analysis is not an isolated laboratory test. It sits at the front end of the entire QC chain and provides water quality data to support subsequent liquid preparation.

Product Recommendation: MedIntegrity TA-3.0 On-line Total Organic Carbon Analyzer

II. Liquid Preparation & Transfer: Focus on Integrity of Process Media and Single-use Systems

After pharmaceutical water quality verification, the process enters liquid preparation, including dissolution, mixing, concentration adjustment and material transfer. For production lines adopting traditional stainless steel systems, controls mainly focus on equipment cleaning, process parameters and material transfer. For single-use production systems, further assessment shall be conducted on the integrity of single-use preparation bags, storage bags and associated components before and after use.

Leaks in single-use systems will not only cause material loss, but also break the original closed condition. Therefore, enterprises adopting single-use process systems may incorporate bag integrity testing into QC workflows based on risk assessment and validation strategies.

MedIntegrity BGT-series bag integrity testers provide integrity detection for single-use bioprocess bags, storage bags and other flexible containers of various specifications. Within the whole solution for lyophilized injectables, this instrument is not a standard configuration for all customers; it is optional for manufacturers adopting single-use preparation, storage or transfer systems.

Product Recommendation: MedIntegrity BGT-200 Bag Integrity Tester

III. Sterile Filtration: Integrity Verification of Critical Aseptic Barriers

After preparation, the bulk solution usually undergoes sterile filtration before entering the aseptic production area. For lyophilized injectables manufactured with sterile filtration, filters undertake the critical function of microbial retention. Their integrity directly determines whether the filtration barrier can function as expected. Thus filter integrity testing is one of the most important QC nodes in full-process quality control for lyophilized injectables.

Filter integrity is not only related to the filter itself; its status can also be affected by sterilization, installation, usage and operating conditions. Upon proper validation, enterprises shall implement integrity tests for critical filters according to process design and QC strategies. In actual testing, appropriate test methods can be selected based on filter type, membrane material, filtration area and process conditions, including bubble point test, diffusion flow test, pressure hold test and water intrusion test.

MedIntegrity filter integrity testers are designed for pharmaceutical filter integrity testing and satisfy relevant filter integrity test requirements.

The value of filter integrity testing for lyophilized injectable manufacturers lies not merely in obtaining a pass/fail result. More importantly, validated test methods objectively confirm the status of critical filtration barriers, making filter integrity a verifiable link within the aseptic manufacturing QC system.

Product Recommendation: MedIntegrity V8.0 Filter Integrity Tester

IV. Aseptic Filling: Incorporate Critical Operational Barriers into Integrity Control

The filtered bulk solution enters the aseptic filling stage. For production lines using isolators or RABS for aseptic operations, physical barriers formed by equipment structure and operation gloves separate operators from products.

During long-term production, operation gloves are subject to repeated handling, mechanical friction, installation and disassembly. Tiny damages may not be detected by routine visual inspection, yet once leakage paths form, the original aseptic barrier will be compromised. Therefore, production lines equipped with isolation systems shall conduct integrity verification of critical gloves following established test procedures.

MedIntegrity glove integrity testers are applicable for glove integrity testing of isolators and relevant aseptic operating systems.

Product Recommendation: MedIntegrity WGT-2200 Glove Integrity Tester

V. Stoppering & Crimping: Integrity Evaluation after Formation of Final Container Closure System

After aseptic filling, vials are partially stoppered and transferred into freeze dryers. After lyophilization, vials are fully stoppered and crimped. Vials, rubber stoppers and aluminum caps together constitute the final container closure system. At this point, products move from lyophilization to final packaging stage, and QC focus shifts to whether the container closure system can form and sustain the expected sealing barrier.

Container closure integrity is determined collectively by vial neck dimension, stopper structure, stoppering condition, crimping process and compatibility of container closure components, rather than only by the stopper itself. Hence evaluation of the complete packaging system shall target the full container closure assembly; test results of individual packaging components cannot replace system-level assessment. For vial-based lyophilized injectables, finished package container closure integrity testing may be performed according to packaging characteristics and validated test methods.

MedIntegrity MFT-R-2000 automated package seal integrity testing system adopts non-destructive testing technology. Compared with visual inspection, instrument-based seal integrity testing delivers objective, recordable test data, applicable to packaging process research, routine QC and stability studies.

Product Recommendation: MedIntegrity MFT-R-2000 Package Seal Integrity Tester

Customized Solution Logic

Lyophilized injectable manufacturers vary greatly in production scale, process routes, equipment formats and packaging systems. There is no fixed equipment combination for integrity QC solutions.

• Enterprises with traditional stainless steel preparation systems may not require bag integrity testing instruments;
• Production lines using isolators for aseptic filling shall prioritize glove integrity testing;
• For lyophilized products packed in vials, container closure integrity testing shall be assessed in combination with the specific packaging system and test methods.

Therefore, when designing solutions, MedIntegrity does not take equipment quantity as the core. Instead, it conducts comprehensive analysis on dosage forms, process routes, critical aseptic barriers, packaging systems and QC requirements based on customers’ actual production lines, then selects suitable testing technologies and equipment. The outcome is a customized integrity QC solution process-based, risk-oriented and supported by testing technologies.

MedIntegrity Full-process Integrity QC Solution for Lyophilized Injectables

Quality assurance of lyophilized injectables runs through the entire product lifecycle. Pharmaceutical water lays the foundation of quality control; sterile filtration achieves microbial retention; aseptic operation barriers isolate production environments from products; freeze-drying continuously maintains specified aseptic protection conditions; stoppering and crimping build the final protective barrier for products. All these links jointly form the quality control chain for lyophilized injectables.

Centered on filter integrity testing and TOC analysis, MedIntegrity combines glove, single-use bag and package seal integrity testing technologies. It flexibly configures solutions according to differentiated requirements of drugs, processes and packaging systems, supporting pharmaceutical manufacturers to establish a full-process integrity QC system covering critical process nodes for lyophilized injectables.